文献速递头颈外科

pT1-2N1M0头颈癌术后放疗或放化疗的使用与生存分析

Utilization and Survival of Postoperative Radiation or Chemoradiation for pT1-2N1M0 Head and Neck Cancer.
PubMed 文献 · Otolaryngol Head Neck Surg · 2017-12-19

基于美国国家癌症数据库2004-2012年1598例pT1-2N1M0头颈鳞癌(切缘阴性、无包膜外侵犯)的回顾性分析显示,35.4%仅手术、45.4%接受术后放疗、19.1%接受术后放化疗;术后放化疗与生存获益相关(HR=0.57),而术后放疗较单纯手术无生存差异(HR=0.88)。

要点

  • 近65%的pT1-2N1M0切缘阴性无包膜外侵犯患者接受了术后放疗或放化疗。

核心结论

  • pT1-2N1M0头颈癌切缘阴性且无包膜外侵犯患者中,仅术后放化疗与生存改善相关,术后放疗较单纯手术无生存差异。

研究设计与样本

  • 回顾性分析美国国家癌症数据库2004-2012年pT1-2N1M0口腔、口咽、下咽或喉鳞癌患者,均接受手术且切缘阴性、无包膜外侵犯,共1598例。

主要发现

  • 566例(35.4%)仅手术,726例(45.4%)接受手术+术后放疗,306例(19.1%)接受手术+术后放化疗。
  • 多因素logistic回归显示学术中心与较低术后放疗(OR=0.71)和术后放化疗(OR=0.66)可能性相关。

临床怎么用

  • 对于pT1-2N1M0头颈鳞癌切缘阴性且无包膜外侵犯患者,术后放化疗可能与生存改善相关,术后放疗较单纯手术未见生存优势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective To analyze the patterns of care and survival for pT1-2N1M0 head and neck cancer based on receipt of surgery alone, surgery + postoperative radiotherapy (S + RT), or surgery + postoperative chemoradiotherapy (S + CRT). Study Design Retrospective analysis. Setting National Cancer Database. Subjects and Methods We queried the database for patients with stage pT1-2N1M0 squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx between 2004 and 2012 who were treated with surgery with negative margins and no extracapsular extension. Logistic regression was used to assess predictors of receipt of postoperative treatment. Overall survival was assessed by the Kaplan-Meier method, and Cox regression analysis identified covariates that affected it. Results There were 1598 patients included in this study: 566 (35.4%) received surgery alone; 726 (45.4%), S + RT; and 306 (19.1%), S + CRT. The 5-year overall survival was 68.8%, 74.0%, and 87.8%, respectively ( P = .009 comparing S + RT and surgery alone, P < .001 for all other comparisons). On multivariable logistic regression, academic centers were associated with a decreased likelihood of S + RT (odds ratio = 0.71) and S + CRT (odds ratio = 0.66). Multivariable Cox regression demonstrated no difference in survival for S + RT over surgery alone (hazard ratio = 0.88, 95% CI = 0.70-1.09, P = .24); however, there was a survival benefit associated with S + CRT (hazard ratio = 0.57, 95% CI = 0.39-0.81, P = .002). Conclusion Nearly 65% of patients with pT1-2N1 head and neck cancer with negative margins and no extracapsular extension received S + RT or S + CRT. Improvement in survival was noted only for patients who received S + CRT.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Lee A, Givi B, Roden DF, et al. Utilization and Survival of Postoperative Radiation or Chemoradiation for pT1-2N1M0 Head and Neck Cancer. Otolaryngol Head Neck Surg. 2017. PMID: 29256329. doi:10.1177/0194599817746391

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。